Prevention of parenteral nutrition-associated liver disease: Lipid minimization

Current Opinion in Organ Transplantation

Volumn 15, Issue 3, 2010, Pages 330-333

  Cober, M Petrea ^a   Teitelbaum, Daniel H ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

Cholestasis; Lipid emulsions and essential fatty acids; Parenteral nutrition

Indexed keywords

FISH OIL; GLUCOSE; LIPOSYN; LIPOSYN III; OMEGAVEN; SOYBEAN OIL EMULSION; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; BILIRUBIN BLOOD LEVEL; CHILD GROWTH; CHILD NUTRITION; CHOLESTASIS; CLINICAL TRIAL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; ESSENTIAL FATTY ACID DEFICIENCY; HUMAN; INFANT; LIVER DISEASE; LIVER PROTECTION; LONG TERM CARE; LOW FAT DIET; PARENTERAL NUTRITION; PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE; PATHOGENESIS; REVIEW; SEPSIS; SIDE EFFECT; SURGICAL PATIENT; WEIGHT GAIN;

BILIRUBIN; CHOLESTASIS; EVIDENCE-BASED MEDICINE; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, ESSENTIAL; HUMANS; INFANT; INFANT, NEWBORN; LIVER DISEASES; NUTRITIONAL STATUS; PARENTERAL NUTRITION; RISK ASSESSMENT; RISK FACTORS; SOYBEAN OIL;

EID: 77953291719     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328338c2da     Document Type: Review

References (28)

1. Andorsky DJ, Lund DP, Lillehei CW, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 2001; 139:5-7.
2. Bueno J, Guiterrez J, Mazariegos GV, et al. Analysis of patients with longitudinal intestinal lengthening procedure referred for intestinal transplantation. J Pediatr Surg 2001; 36:178-183.
3. Wales PW, de Silva N, Kim J, et al. Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. J Pediatr Surg 2004; 39:690-695.
4. Teitelbaum DH, Drongowski R, Spivak D. Rapid development of hyperbilirubinemia in infants with the short bowel syndrome as a correlate to mortality: possible indication for early small bowel transplantation. Transplant Proc 1996; 28:2699-2700.
5. Spencer AU, Neaga A, West B, et al. Mortality and outcomes of pediatric short bowel syndrome: redefining predictors of success. Ann Surg 2005; 242:403-409.
6. Sigalet D, Boctor D, Robertson M, et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg 2009; 19:348-353.
7. Btaiche IF, Khalidi N. Parenteral nutrition-associated liver complications in children. Pharmacotherapy 2002; 22:188-211.
8. Teitelbaum DH, Tracy T. Parenteral nutrition-associated cholestasis. Semin Pediatr Surg 2001; 10:72-80.
9. Tazuke Y, Kiristioglu I, Heidelberger KP, et al. Hepatic P-glycoprotein changes with total parenteral nutrition administration. JPEN J Parenter Enteral Nutr 2004; 28:1-6.
10. Tazuke Y, Teitelbaum DH. Alteration of canalicular transporters in a mouse model of total parenteral nutrition. Pediatr Gastroenterol Nutr 2009; 48:193-202.
11. Allardyce DB. Cholestasis caused by lipid emulsions. Surg Gynecol Obstet 1982; 154:641-647.
12. CavicchiM, Crenn P, Beau P, et al. Severe liver complications associated with long-term parenteral nutrition are dependent on lipid parenteral input. Transplant Proc 1998; 30:2547.
13. Cavicchi M, Beau P, Crenn P, et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000; 132:525-532.
14. Colomb V, Jobert-Giraud A, Lacaille F, et al. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr 2000; 24(6): 345-350.
15. Shin JI, Namgung R, Park MS, et al. Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates? Eur J Pediatr 2008; 167:197-202.
16. Tazuke Y, Drongowski RA, Btaiche I, et al. Effects of lipid administration on liver apoptotic signals in a mouse model of total parenteral nutrition (TPN). Pediatr Surg Int 2004; 20:224-228.
17. Kast HR, Goodwin B, Tarr PT, et al. Regulation of multidrug resistanceassociated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. Biol Chem 2002; 277:2908-2915.
18. Carter BA, Taylor OA, Prendergast DR, et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res 2007; 62:301-306.
19. Clayton PT, Bowron A, Mills KA, et al. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993; 105:1806-1813.
20. Iyer KR, Spitz L, Clayton P. BAPS prize lecture: new insight into mechanisms of parenteral nutrition-associated cholestasis - role of plant sterols. British Association of Paediatric Surgeons. J Pediatr Surg 1998; 33:1-6.
21. Meurling S, Roos KA. Liver changes in rats on continuous and intermittent parenteral nutrition with and without fat (Intralipid 20%). Acta Chir Scand 1981; 147:475-480. (Pubitemid 12233572)
22. Oshita M, Takehara H, Yamaguchi M, et al. Significance of administration of fat emulsion: hepatic changes in infant rats receiving total parenteral nutrition with and without fat. Clin Nutr 2004; 23:1060-1068.
23. de Meijer VE, Gura KM, Meisel JA, et al. Parenteral fish oil as monotherapy for patients with parenteral nutrition-associated liver disease. Pediatr Surg Int 2009; 25:123-124.
24. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009; 250:395-402.
25. West B, Welch K, Galecki A. Linear mixed models: a practical guide using statistical software. Boca Raton, Florida: Chapman and Hall; 2006.
26. ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 2002; 26 (Suppl 1): 1SA-138SA.
27. Gutcher GR, Farrell PM. Intravenous infusion of lipid for the prevention of essential fatty acid deficiency in premature infants. Am J Clin Nutr 1991; 54:1024-1028.
28. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008; 121:e678-e686.